Literature DB >> 28213503

Inhibition of Inflammatory Gene Transcription by IL-10 Is Associated with Rapid Suppression of Lipopolysaccharide-Induced Enhancer Activation.

Evan A Conaway1, Dalila C de Oliveira1, Christine M McInnis1,2, Scott B Snapper3,4, Bruce H Horwitz5,2.   

Abstract

IL-10 limits the magnitude of inflammatory gene expression following microbial stimuli and is essential to prevent inflammatory disease; however, the molecular basis for IL-10-mediated inhibition remains elusive. Using a genome-wide approach, we demonstrate that inhibition of transcription is the primary mechanism for IL-10-mediated suppression in LPS-stimulated macrophages and that inhibited genes can be divided into two clusters. Genes in the first cluster are inhibited only if IL-10 is included early in the course of LPS stimulation and is strongly enriched for IFN-inducible genes. Genes in the second cluster can be rapidly suppressed by IL-10 even after transcription is initiated, and this is associated with suppression of LPS-induced enhancer activation. Interestingly, the ability of IL-10 to rapidly suppress active transcription exhibits a delay following LPS stimulation. Thus, a key pathway for IL-10-mediated suppression involves rapid inhibition of enhancer function during the secondary phase of the response to LPS.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28213503      PMCID: PMC5369026          DOI: 10.4049/jimmunol.1601781

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages.

Authors:  Andrew Paul Hutchins; Stéphane Poulain; Diego Miranda-Saavedra
Journal:  Blood       Date:  2012-02-09       Impact factor: 22.113

2.  Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10.

Authors:  Roopa Biswas; Shyamasree Datta; Jaydip Das Gupta; Michael Novotny; Julie Tebo; Thomas A Hamilton
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

4.  Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages.

Authors:  Serena Ghisletti; Iros Barozzi; Flore Mietton; Sara Polletti; Francesca De Santa; Elisa Venturini; Lorna Gregory; Lorne Lonie; Adeline Chew; Chia-Lin Wei; Jiannis Ragoussis; Gioacchino Natoli
Journal:  Immunity       Date:  2010-03-04       Impact factor: 31.745

5.  Latent enhancers activated by stimulation in differentiated cells.

Authors:  Renato Ostuni; Viviana Piccolo; Iros Barozzi; Sara Polletti; Alberto Termanini; Silvia Bonifacio; Alessia Curina; Elena Prosperini; Serena Ghisletti; Gioacchino Natoli
Journal:  Cell       Date:  2013-01-17       Impact factor: 41.582

6.  Fast gapped-read alignment with Bowtie 2.

Authors:  Ben Langmead; Steven L Salzberg
Journal:  Nat Methods       Date:  2012-03-04       Impact factor: 28.547

7.  Control of inducible gene expression by signal-dependent transcriptional elongation.

Authors:  Diana C Hargreaves; Tiffany Horng; Ruslan Medzhitov
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

8.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.

Authors:  M Aste-Amezaga; X Ma; A Sartori; G Trinchieri
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

9.  CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice.

Authors:  Susan E Erdman; Varada P Rao; Theofilos Poutahidis; Melanie M Ihrig; Zhongming Ge; Yan Feng; Michal Tomczak; Arlin B Rogers; Bruce H Horwitz; James G Fox
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses.

Authors:  Ido Amit; Manuel Garber; Nicolas Chevrier; Ana Paula Leite; Yoni Donner; Thomas Eisenhaure; Mitchell Guttman; Jennifer K Grenier; Weibo Li; Or Zuk; Lisa A Schubert; Brian Birditt; Tal Shay; Alon Goren; Xiaolan Zhang; Zachary Smith; Raquel Deering; Rebecca C McDonald; Moran Cabili; Bradley E Bernstein; John L Rinn; Alex Meissner; David E Root; Nir Hacohen; Aviv Regev
Journal:  Science       Date:  2009-09-03       Impact factor: 47.728

View more
  12 in total

1.  IL-17 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas.

Authors:  Rao Me; Nan Gao; Chenyang Dai; Fu-Shin X Yu
Journal:  J Immunol       Date:  2019-11-25       Impact factor: 5.422

Review 2.  Cytokines that target immune killer cells against tumors.

Authors:  Jian Qiao; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2020-06-10       Impact factor: 11.530

3.  Loss of Interleukin-10 (IL-10) Signaling Promotes IL-22-Dependent Host Defenses against Acute Clostridioides difficile Infection.

Authors:  Emily S Cribas; Joshua E Denny; Jeffrey R Maslanka; Michael C Abt
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

4.  Single-cell secretion analysis reveals a dual role for IL-10 in restraining and resolving the TLR4-induced inflammatory response.

Authors:  Amanda F Alexander; Ilana Kelsey; Hannah Forbes; Kathryn Miller-Jensen
Journal:  Cell Rep       Date:  2021-09-21       Impact factor: 9.423

5.  Effects of IL-10 on OX62, MHC-II and CD86 in bone marrow DCs in rats with organophosphate poisoning.

Authors:  Ning Wang; Jinfeng Wang; Ronggang Jiang
Journal:  Exp Ther Med       Date:  2017-12-14       Impact factor: 2.447

6.  Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2.

Authors:  Subhankar Mukhopadhyay; Eva Heinz; Immacolata Porreca; Kaur Alasoo; Amy Yeung; Huei-Ting Yang; Tobias Schwerd; Jessica L Forbester; Christine Hale; Chukwuma A Agu; Yoon Ha Choi; Julia Rodrigues; Melania Capitani; Luke Jostins-Dean; David C Thomas; Simon Travis; Daniel Gaffney; William C Skarnes; Nicholas Thomson; Holm H Uhlig; Gordon Dougan; Fiona Powrie
Journal:  J Exp Med       Date:  2020-02-03       Impact factor: 14.307

7.  Impact of Interleukin 10 Deficiency on Intestinal Epithelium Responses to Inflammatory Signals.

Authors:  Stamatia Papoutsopoulou; Liam Pollock; Catherine Walker; William Tench; Sakim Shakh Samad; François Bergey; Luca Lenzi; Raheleh Sheibani-Tezerji; Phillip Rosenstiel; Mohammad Tauqeer Alam; Vitor A P Martins Dos Santos; Werner Müller; Barry J Campbell
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

8.  Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor.

Authors:  Naresh S Redhu; Vasudevan Bakthavatchalu; Evan A Conaway; Dror S Shouval; Amy Tsou; Jeremy A Goettel; Amlan Biswas; Chuanwu Wang; Michael Field; Werner Muller; Andre Bleich; Ning Li; Georg K Gerber; Lynn Bry; James G Fox; Scott B Snapper; Bruce H Horwitz
Journal:  Elife       Date:  2017-07-05       Impact factor: 8.140

9.  Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.

Authors:  Theodore P Braun; Mariam Okhovat; Cody Coblentz; Sarah A Carratt; Amy Foley; Zachary Schonrock; Brittany M Curtiss; Kimberly Nevonen; Brett Davis; Brianna Garcia; Dorian LaTocha; Benjamin R Weeder; Michal R Grzadkowski; Joey C Estabrook; Hannah G Manning; Kevin Watanabe-Smith; Sophia Jeng; Jenny L Smith; Amanda R Leonti; Rhonda E Ries; Shannon McWeeney; Cristina Di Genua; Roy Drissen; Claus Nerlov; Soheil Meshinchi; Lucia Carbone; Brian J Druker; Julia E Maxson
Journal:  Nat Commun       Date:  2019-11-29       Impact factor: 17.694

Review 10.  Biology and therapeutic potential of interleukin-10.

Authors:  Margarida Saraiva; Paulo Vieira; Anne O'Garra
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.